We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$4.92B
AUM Growth
+$1.62B
Cap. Flow
+$1.41B
Cap. Flow %
28.67%
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$208M
2
AMZN icon
Amazon
AMZN
+$165M
3
AMD icon
Advanced Micro Devices
AMD
+$86.9M
4
XYZ
Block Inc
XYZ
+$33.2M
5
ROKU icon
Roku
ROKU
+$27M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$10.3M
2
MRNA icon
Moderna
MRNA
+$9.79M
3
JD icon
JD.com
JD
+$6.14M
4
AZN icon
AstraZeneca
AZN
+$5.27M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.32M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.5%
2 Technology 4.33%
3 Communication Services 2.49%
4 Healthcare 1.87%
5 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URA icon
1301
Global X Uranium ETF
URA
$5.21B
-35,000
Closed -$924K
UTHR icon
1302
CALL
United Therapeutics
UTHR
$26.1B
-10,000
Closed -$1.85M
UTHR icon
1303
United Therapeutics
UTHR
$26.1B
-6,000
Closed -$1.11M
UTHR icon
1304
PUT
United Therapeutics
UTHR
$26.1B
-50,000
Closed -$9.23M
V icon
1305
CALL
Visa
V
$701B
-6,000
Closed -$1.34M
V icon
1306
PUT
Visa
V
$701B
-7,000
Closed -$1.56M
VEEV icon
1307
CALL
Veeva Systems
VEEV
$33.8B
-20,000
Closed -$5.76M
VEEV icon
1308
Veeva Systems
VEEV
$33.8B
-11,000
Closed -$3.17M
VEEV icon
1309
PUT
Veeva Systems
VEEV
$33.8B
-20,000
Closed -$5.76M
VFC icon
1310
VF Corp
VFC
$5.92B
-7,000
Closed -$511K
VIR icon
1311
CALL
Vir Biotechnology
VIR
$1.46B
-50,000
Closed -$2.18M
VIR icon
1312
Vir Biotechnology
VIR
$1.46B
-81,500
Closed -$3.55M
VRRM icon
1313
CALL
Verra Mobility
VRRM
$779M
-99,500
Closed -$1.5M
VSXY
1314
CALL
Victoria's Secret
VSXY
$7.09B
-25,000
Closed -$1.38M
VTLE
1315
PUT
DELISTED
Vital Energy
VTLE
-1,500
Closed -$122K
VTR icon
1316
CALL
Ventas
VTR
$47.5B
-129,500
Closed -$7.15M
VTR icon
1317
Ventas
VTR
$47.5B
-10,000
Closed -$552K
VTR icon
1318
PUT
Ventas
VTR
$47.5B
-119,500
Closed -$6.6M
VTRS icon
1319
CALL
Viatris
VTRS
$20.8B
-50,000
Closed -$678K
WHR icon
1320
Whirlpool
WHR
$2.49B
-1,000
Closed -$220K
WM icon
1321
CALL
Waste Management
WM
$95B
-33,500
Closed -$5M
WST icon
1322
CALL
West Pharmaceutical
WST
$23.7B
-7,600
Closed -$3.23M
WST icon
1323
PUT
West Pharmaceutical
WST
$23.7B
-7,600
Closed -$3.23M
XENE icon
1324
CALL
Xenon Pharmaceuticals
XENE
$6.1B
-38,800
Closed -$593K
XENE icon
1325
PUT
Xenon Pharmaceuticals
XENE
$6.1B
-30,000
Closed -$458K

Similar funds

SG3 Management's Q4 2021 Portfolio in Review

As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.

  • SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
  • SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
  • SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
  • SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
  • SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
  • SG3 Management opened 468 new positions and closed 410 in Q4 2021.
  • SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.